Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT) also known as Hashimoto's encephalopathy (HE), is a rare immunemediated complication independent of functional status of thyroid, which leads to either stroke-like symptoms, or presents as diffuse progressive symptoms of altered mental status, seizures, and cognitive dysfunction. Here we present a case of SREAT in a female with recurrent episodes.
Case History:
A 54-year-old female was brought in by ambulance after a prolonged tonic-clonic generalised seizure, requiring intubation with a Glasgow coma scale (GCS) of 6/15. Her past medical history was significant for autoimmune hyperthyroidism, epilepsy, smoker and alcohol excess. She did have previous ITU admissions with a similar episodes and after ruling out all possible causes of encephalitis; was treated as SREAT (based on EEG, thyroid history and cerebrospinal fluid (CSF) raised protein); with a 5 day course of i.v. methylprednisolone with good response. Her medications included propylthiouracil (PTU) 50mg twice-a-day and levetiracetam 1250 mg twice-a-day.
Treatment:
While sedated she continued to be in non-convulsive status. With the background of autoimmune thyroiditis/possible SREAT and above mentioned investigations, a trial of methylprednisolone 1 g i.v. was given for 5 days with dramatic improvement in her mental status and GCS within 24 hours. She was discharged on tapering dose of steroids. 
